Halozyme (HALO) Stock Research

Today

Halozyme price target raised by $20 at Wells Fargo, here's why

HALO

7:01 AM

Friday

Halozyme price target raised by $12 at Morgan Stanley

HALO

Aug 7, 9:39 AM

Halozyme price target raised by $9 at TD Cowen, here's why

HALO

Aug 7, 9:21 AM

Halozyme price target raised by $20 at Wells Fargo, here's why

HALO

Aug 7, 7:21 AM

Leerink upgraded Halozyme to Outperform on growth, market leadership

HALO

Aug 7, 7:07 AM

Leerink gets more bullish on Halozyme, upgrades shares

HALO

Aug 7, 6:59 AM

Halozyme price target raised by $1 at Citizens, here's why

HALO

Aug 7, 6:12 AM

Halozyme price target raised by $20 at H.C. Wainwright, here's why

HALO

Aug 7, 6:07 AM

Thursday

Halozyme raises 2026 non-GAAP EPS view to $8.65-$9.00 from $7.75 to $8.25

HALO

Aug 6, 4:08 PM

Halozyme reports Q2 non-GAAP EPS $2.28, consensus $1.82

HALO

Aug 6, 4:06 PM

Over a week ago

Halozyme announces global collaboration, license agreement with Incyte

Jul 20, 8:01 AM

LifeMD partners with Halozyme subsidiary for exclusive testosterone program

Jun 22, 9:27 AM

Halozyme price target lowered by $3 at Morgan Stanley, here's why

HALO

May 12, 8:05 AM

Halozyme still sees 2026 non-GAAP EPS $7.75 to $8.25, consensus $8.09

HALO

May 11, 4:04 PM

Halozyme reports Q1 non-GAAP EPS $1.60, consensus $1.52

HALO

May 11, 4:03 PM

Halozyme announces global collaboration and license agreement with GSK

May 7, 9:03 AM

Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis

May 6, 8:15 AM

Halozyme names Darren Snellgrove as CFO

Apr 30, 8:03 AM

Halozyme price target raised by $5 at H.C. Wainwright, here's why

HALO

Apr 29, 6:10 AM

Halozyme price target raised by $2 at Morgan Stanley, here's why

HALO

Apr 21, 8:43 AM

Halozyme enters global global collaboration and license agreement with Vertex

Apr 7, 8:02 AM

Halozyme names David Ramsay as Interim CFO

HALO

Mar 12, 8:31 AM

Halozyme price target raised by $16 at Morgan Stanley, here's why

HALO

Feb 19, 8:43 AM

Halozyme price target raised by $15 at Benchmark, here's why

HALO

Feb 19, 8:34 AM

Halozyme price target raised by $10 at Wells Fargo, here's why

HALO

Feb 19, 6:28 AM

Today

Halozyme price target raised by $20 at Wells Fargo, here's why

HALO

7:01 AM

Friday

Halozyme price target raised by $12 at Morgan Stanley

HALO

Aug 7, 9:39 AM

Halozyme price target raised by $9 at TD Cowen, here's why

HALO

Aug 7, 9:21 AM

Halozyme price target raised by $20 at Wells Fargo, here's why

HALO

Aug 7, 7:21 AM

Leerink upgraded Halozyme to Outperform on growth, market leadership

HALO

Aug 7, 7:07 AM

Leerink gets more bullish on Halozyme, upgrades shares

HALO

Aug 7, 6:59 AM

Halozyme price target raised by $1 at Citizens, here's why

HALO

Aug 7, 6:12 AM

Halozyme price target raised by $20 at H.C. Wainwright, here's why

HALO

Aug 7, 6:07 AM

Thursday

Halozyme raises 2026 non-GAAP EPS view to $8.65-$9.00 from $7.75 to $8.25

HALO

Aug 6, 4:08 PM

Halozyme reports Q2 non-GAAP EPS $2.28, consensus $1.82

HALO

Aug 6, 4:06 PM

Over a week ago

Halozyme announces global collaboration, license agreement with Incyte

Jul 20, 8:01 AM

LifeMD partners with Halozyme subsidiary for exclusive testosterone program

Jun 22, 9:27 AM

Halozyme price target lowered by $3 at Morgan Stanley, here's why

HALO

May 12, 8:05 AM

Halozyme still sees 2026 non-GAAP EPS $7.75 to $8.25, consensus $8.09

HALO

May 11, 4:04 PM

Halozyme reports Q1 non-GAAP EPS $1.60, consensus $1.52

HALO

May 11, 4:03 PM

Halozyme announces global collaboration and license agreement with GSK

May 7, 9:03 AM

Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis

May 6, 8:15 AM

Halozyme names Darren Snellgrove as CFO

Apr 30, 8:03 AM

Halozyme price target raised by $5 at H.C. Wainwright, here's why

HALO

Apr 29, 6:10 AM

Halozyme price target raised by $2 at Morgan Stanley, here's why

HALO

Apr 21, 8:43 AM

Halozyme enters global global collaboration and license agreement with Vertex

Apr 7, 8:02 AM

Halozyme names David Ramsay as Interim CFO

HALO

Mar 12, 8:31 AM

Halozyme price target raised by $16 at Morgan Stanley, here's why

HALO

Feb 19, 8:43 AM

Halozyme price target raised by $15 at Benchmark, here's why

HALO

Feb 19, 8:34 AM

Halozyme price target raised by $10 at Wells Fargo, here's why

HALO

Feb 19, 6:28 AM

Company News

Charts